Akt, also known as protein kinase B, has a central role in various signaling pathways that regulate cellular processes such as metabolism, proliferation and survival. On stimulation, phosphorylation of the activation loop (Aloop) and hydrophobic motif (HM) of Akt by the kinase phosphoinositide-dependent kinase 1 (PDK1) and the mammalian target of rapamycin complex 2 (mTORC2), respectively, results in Akt activation. A well-conserved threonine in the turn motif (TM) is also constitutively phosphorylated by mTORC2 and contributes to the stability of Akt. The role of TM phosphorylation in HM and A-loop phosphorylation has not been sufficiently evaluated. Using starfish oocytes as a model system, this study provides the first evidence that TM phosphorylation has a negative role in A-loop phosphorylation. In this system, the maturation-inducing hormone, 1-methyladenine, stimulates Akt to reinitiate meiosis through activation of cyclin B-Cdc2. The phosphorylation status of Akt was monitored via introduction of exogenous human Akt (hAkt) in starfish oocytes. TM and HM phosphorylation was inhibited by microinjection of an anti-starfish TOR antibody, but not by rapamycin treatment, suggesting that both phosphorylation events depend on TORC2, as reported in mammalian cells. A single or double alanine substitution at each of three phosphorylation residues revealed that TM phosphorylation renders Akt susceptible to dephosphorylation on the A-loop. When A-loop phosphatase was inhibited by okadaic acid (OA), TM phosphorylation still reduced Aloop phosphorylation, suggesting that the effect is caused at least partially through reduction of sensitivity to PDK1. Negative regulation by TM phosphorylation was also observed in constitutively active Akt and was functionally reflected in meiosis resumption. By contrast, HM phosphorylation enhanced A-loop phosphorylation and achieved full activation of Akt via a mechanism at least partially independent of TM phosphorylation. These observations provide new insight into the mechanism controlling Akt phosphorylation in the cell.
Introduction
Akt/protein kinase B is an essential kinase in various signal transduction pathways activated by extracellular agonists, such as insulin and growth factors. Akt regulates diverse cellular functions, including glucose metabolism and cell survival (Fayard et al., 2005; Manning and Cantley, 2007) . Dysregulation of Akt has been observed in human diseases, including cancers (Restuccia and Hemmings, 2010) . Thus, understanding the molecular mechanism of Akt activation is important for basic biology and therapeutic development. Akt activation has been investigated mainly in mammalian cells. Downstream of the stimulus, activation of phosphatidylinositol-3-OH kinase (PI3K) produces phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the plasma membrane. Akt is activated through phosphorylation in a PIP3-dependent manner at two conserved residues, threonine (human: Thr308) in the activation loop (A-loop) and serine (human: Ser473) in the C-terminal hydrophobic motif (HM) (Alessi et al., 1996) . These phosphorylation reactions are catalyzed by phosphoinositide-dependent kinase-1 (PDK1) (Alessi et al., 1997a, b) and the mammalian target of rapamycin complex 2 (mTORC2) (Sarbassov et al., 2005) , respectively. One of the controversial issues in the activation process of Akt is the mutual dependency of A-loop phosphorylation and HM phosphorylation. Some reports indicate that both reactions occur independently of each other (Alessi et al., 1996; Hill et al., 2001) , whereas others indicate that HM phosphorylation depends on A-loop phosphorylation (Toker and Newton, 2000) . Furthermore, adverse dependency has been observed (Scheid et al., 2002; Goren et al., 2008) . The situation is even more confusing when considering the disruption of mTORC2-dependent HM phosphorylation. Inhibition of mTORC2 by chemical inhibitors or RNA interference results in diminished HM phosphorylation and decreased A-loop phosphorylation (Sarbassov et al., 2005 (Sarbassov et al., , 2006 Feldman et al., 2009; Garcı´a-Martı´nez et al., 2009 ). However, A-loop phosphorylation was not disrupted in the absence of HM phosphorylation in mouse embryonic fibroblasts from mTORC2 component-knockout mice (Guertin et al., 2006; Jacinto et al., 2006; Facchinetti et al., 2008; Ikenoue et al., 2008; Feldman et al., 2009; Garcı´a-Martı´nez et al., 2009) . These discrepancies have not been explained sufficiently and imply the existence of an unknown mechanism that controls Akt phosphorylation.
Akt has another well-conserved threonine phosphorylation site (human: Thr450) in the turn motif (TM). This Thr residue is constitutively phosphorylated in the absence of extracellular stimuli (Alessi et al., 1996) , depending on mTORC2 (Facchinetti et al., 2008; Ikenoue et al., 2008) . Structural studies have suggested that this modification contributes to the correct conformation of Akt (Hauge et al., 2007) . Early Akt activation studies showed that TM phosphorylation is not essential for phosphorylation of the other sites (Toker and Newton, 2000) ; however, considering the emerging complexity of the Akt activation mechanism, such as the discrepancy over the mutual dependency of A-loop and HM phosphorylation, the involvement of TM phosphorylation in the phosphorylation of the A-loop and/or the HM needs to be re-evaluated.
In this study, the role of TM phosphorylation in Aloop and HM phosphorylation was investigated using starfish oocytes, which provide a good model for Akt signaling (Kishimoto, 2003) . Immature starfish oocytes arrest their cell cycle at prophase in the first meiotic division. An extracellular stimulus, provided by the maturation-inducing hormone 1-methyladenine (1-MeAde) (Kanatani et al., 1969) , activates cyclin BCdc2 and releases the arrest in a process known as meiotic re-initiation, which is equivalent to the G2/Mphase transition. The oocytes then complete meiosis and become fertilizable mature eggs (Kishimoto, 2003) . Downstream of 1-MeAde signaling (Chiba et al., 1993; Jaffe et al., 1993) , the PI3K-Akt pathway is activated (Sadler and Ruderman, 1998; Okumura et al., 2002; Hiraoka et al., 2004) . Akt directly phosphorylates and inhibits Myt1, which phosphorylates Cdc2 on Tyr15 and keeps cyclin B-Cdc2 inactive in immature oocytes, thus triggering meiotic re-initiation (Okumura et al., 2002) .
All three phosphorylation sites in mammalian Akt are conserved in starfish Akt (sfAkt: Thr315 in the A-loop, Thr457 in the TM, and Ser477 in the HM). In vivo labeling of endogenous sfAkt showed phosphorylation during meiotic re-initiation (Okumura et al., 2002) . In addition, A-loop and HM phosphorylation were detected within 3 min after 1-MeAde using exogenously introduced human Akt1 (hAkt) protein and phosphospecific antibodies (Hiraoka et al., 2004) . PDK1 is required for A-loop phosphorylation (Hiraoka et al., 2004) , as reported in mammalian cells; however, the phosphorylation status of the TM and the kinases responsible for both TM and HM phosphorylation remain unknown in starfish oocytes. These previous studies shed light on the potential of starfish oocytes for investigating the mutual dependency of A-loop, TM and HM phosphorylation in Akt.
In this study, TM and HM phosphorylation are shown to depend on TOR in starfish oocytes. In this model, TM phosphorylation has a negative effect on Aloop phosphorylation, resulting in reduced Akt biological activity. HM phosphorylation overcomes this negative effect and allows A-loop phosphorylation to occur.
Results

Detection of Akt phosphorylation in starfish oocytes
To investigate the phosphorylation of Akt in starfish oocytes, we attempted to raise phospho-specific antibodies against the three sites of starfish Akt. Phospho-HM-specific antibodies were successfully generated. The HM of endogenous Akt was phosphorylated within 3 min of 1-MeAde treatment (Figure 1a ). To detect phosphorylation of the A-loop and TM in addition to that of the HM, we introduced exogenous hAkt. The mRNA encoding untagged wild-type (WT) hAkt was injected into immature starfish oocytes. After incubation for 3 h, 1-MeAde was added. Immunoblot analysis with anti-phospho-hAkt-specific antibodies showed that Figure 1 Phosphorylation of Akt after addition of 1-MeAde in starfish oocytes. (a) Immature starfish oocytes were treated with 0.5 mM 1-MeAde, followed by immunoblotting for phosphorylated and total sfAkt (pS477 and sfAkt, respectively). (b) mRNA encoding WT hAkt was injected into immature starfish oocytes (5 pg/oocyte). After incubation for 3 h, the oocytes were treated with 0.5 mM 1-MeAde for the times indicated. Expression and phosphorylation of hAkt were analyzed by immunoblotting with anti-phospho-hAkt (pT308, pT450, pS473) and anti-hAkt C-term (hAkt) antibodies. Uninjected immature oocytes were loaded as a control. (c) mRNA encoding a hAkt kinase-negative mutant (K179A) was injected into immature oocytes (5 pg/oocyte for 3 h incubation, 1 pg/oocyte for 20-40 h incubation). After incubation for the times indicated, the oocytes were analyzed by immunoblotting. As a positive control, mRNA-injected oocytes were incubated for 3 h and then treated with 0.5 mM 1-MeAde for 6 min.
Mutual phosphorylation of Akt on conserved motifs D Hiraoka et al exogenous hAkt was phosphorylated at all three residues within 3 min of 1-MeAde treatment (Figure 1b ). Under our experimental conditions, the TM in exogenous hAkt was not phosphorylated in unstimulated immature oocytes (Figure 1b) , unlike in mammalian cells (Alessi et al., 1996) . This may be due to slow phosphorylation kinetics at this site because phosphorylation of the TM in exogenous kinase-dead hAkt (K179A) was observed after prolonged incubation in immature oocytes (Figure 1c) . The use of a kinase-dead mutant excluded the possibility that TM phosphorylation was caused by basal activity of hAkt. We decided to use a 3-h incubation period for hAkt expression in all subsequent experiments, because a longer incubation period produced a toxic response in some of the mRNAinjected oocytes (data not shown). Under these conditions, the TM was phosphorylated shortly after 1-MeAde was added (Figure 1b) , indicating that the conditions were sufficient for evaluating the role of TM phosphorylation (see below).
Both TM and HM phosphorylation depend on starfish homolog of TOR in starfish oocytes The next step was to examine whether TM and HM phosphorylation depend on TOR in starfish oocytes. We cloned the complementary DNA of the starfish homolog of mTOR (sfTOR, the sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession No. AB556737) and raised a specific antibody (Supplementary Figures S1, S2a and b) . Immunoblot analysis confirmed that the sfTOR protein does exist in starfish oocytes (Figure 2a) . In oocytes injected with anti-sfTOR antibody, germinal vesicle breakdown (GVBD), a hallmark of meiotic resumption, was not observed after 1-MeAde addition (Figure 2b ). In these oocytes, HM and TM phosphorylation was disrupted but A-loop phosphorylation occurred (Figure 2c) . Thus, the phosphorylation of both TM and HM depends on the presence of sfTOR in starfish oocytes, and A-loop phosphorylation alone is not sufficient for induction of meiotic resumption.
In mammals, there are two types of mTOR complex, mTOR complex 1 (mTORC1) and mTORC2 (Bhaskar and Hay, 2007; Ma and Blenis, 2009) . They have different components and substrate specificities. To exclude possible involvement of TORC1 in Akt phosphorylation in starfish oocytes, we used a TORC1 inhibitor, rapamycin. As a positive control, rapamycin inhibited the mobility shift of eIF4E-binding protein (4E-BP) (Supplementary Figure S3) , a well-known target of TORC1 Pause et al., 1994; Brunn et al., 1997; Ma and Blenis, 2009 ). However, Akt phosphorylation upon 1-MeAde stimulus was not affected (Supplementary Figure S3) , supporting the involvement of TORC2, but not TORC1, in Akt phosphorylation in starfish oocytes.
TM phosphorylation does not affect HM phosphorylation
The role of TM phosphorylation was re-evaluated using the starfish oocyte system. The effect of the disruption of TM phosphorylation on HM phosphorylation was examined using the T308A mutant in order to avoid A-loop phosphorylation-dependent effects. On addition of 1-MeAde, the HM and TM of the hAkt T308A mutant were phosphorylated to the same extent as WThAkt (Figure 3 ), which is consistent with the response to PDK1 inhibition (Supplementary Figure S4) . The additional substitution of Thr450 with Ala had no effect on HM phosphorylation (Figure 3 , T308A versus After incubation for 45 min at room temperature, 0.5 mM 1-MeAde was added, followed by monitoring of GVBD as a hallmark of meiotic resumption. GVBD was not observed in oocytes injected with anti-sfTOR antibody at concentrations higher than 35 mg/ml. The graph shows a representative experiment from three separate experiments. The 'n' in the parentheses indicates the number of oocytes injected with each amount of antibody. (c) mRNA encoding WT hAkt was injected into immature starfish oocytes (5 pg/oocyte). After incubation for 3 h, control IgG or anti-sfTOR antibody (final 75 mg/ml) was injected. After an additional 45-min incubation, the oocytes were treated with 0.5 mM 1-MeAde. The phosphorylation status of hAkt (pT308, pT450, pS473) and of endogenous sfAkt (pS477) was analyzed by immunoblotting.
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T308A/T450A). These results indicate that HM phosphorylation is independent of TM phosphorylation.
TM phosphorylation has a negative role in A-loop phosphorylation
The potential role of TM phosphorylation in A-loop phosphorylation was investigated. To avoid HM phosphorylation-dependent effects, the S473A mutant was used. In the S473A mutant, A-loop phosphorylation was abolished (B10% compared with WT) with normal TM phosphorylation ( Figure 4a , WT versus S473A), but was restored by the additional Ala substitution of Thr450 (B70% compared with WT; Figure 4a , S473A versus T450A/S473A), suggesting that TM phosphorylation has a negative role in A-loop phosphorylation.
One possible explanation for this phenomenon is that TM phosphorylation renders Akt more susceptible to Aloop dephosphorylation in the absence of HM phosphorylation. According to this model, phosphorylation of the A-loop could occur, at least initially, in a subpopulation of Akt molecules, in which the TM has not yet been phosphorylated; however, the phosphate on the A-loop would be removed following TM phosphorylation in the absence of HM phosphorylation. This theory was confirmed by the observation that the A-loop of S473A mutant was partially phosphorylated within 1 min of 1-MeAde addition, and then immediately dephosphorylated with increasing TM phosphorylation (Figure 4b ). Thus, in the absence of HM phosphorylation, Akt cannot maintain the phosphate on the A-loop even in 1-MeAde-stimulated oocytes.
TM phosphorylation may decrease the sensitivity to PDK1 The phosphorylation state is determined by the balance between kinase activity and phosphatase activity. Thus, the mechanism by which TM phosphorylation inhibits A-loop phosphorylation would be explained by decreased sensitivity to PDK1 and/or increased sensitivity to a putative A-loop phosphatase. To determine which of these two phenomena is occurring, we tried to inhibit the A-loop phosphatase in vivo. We used okadaic acid (OA) to inhibit the A-loop phosphatase as protein phosphatase 2A has been reported to be an Aloop phosphatase in mammalian cells (Andjelkovicé t al., 1996; Sato et al., 2000; Borgatti et al., 2003; Ugi et al., 2004; Kuo et al., 2008) . Microinjection of OA into unstimulated oocytes induced A-loop phosphorylation in the absence of 1-MeAde (Figure 5a ), as expected from the constitutive activity of PDK1 (Alessi et al., 1997a, b; Hiraoka et al., 2004) . In these oocytes, TM and HM phosphorylation also occurred ( Figure 5a , see Discussion).
The extent of OA-induced A-loop phosphorylation was assessed in the presence and absence of TM phosphorylation. For proper evaluation of the effect of TM phosphorylation, TM must be phosphorylated before A-loop phosphorylation. To induce TM phosphorylation before OA injection, we carried out a short period of 1-MeAde pre-treatment where 1-MeAde was added for 3 min and then washed out. Such treatment was insufficient to cause meiotic re-initiation (Guerrier and Doree, 1975) , as indicated by sustained levels of the suppressive phosphorylation of Cdc2 on Tyr15 (Figure 5b ). Importantly, on removal of 1-MeAde, hAkt was phosphorylated and then dephosphorylated on the A-loop and HM but not on the TM, resulting in production of TM-phosphorylated hAkt (Figures 5b  and c) . Subsequently, the effect of TM phosphorylation on A-loop phosphorylation was assessed in 1-MeAdepre-treated oocytes after OA injection or 1-MeAde retreatment. Diminished A-loop phosphorylation was observed after re-treatment with 1-MeAde in the S473A mutant (B20% compared with the T450A/ S473A mutant) (Figure 5c , lane 4 versus lane 9), indicating that the negative effect of TM phosphorylation still functioned in these oocytes. After OA injection, the level of A-loop phosphorylation in the presence of TM phosphorylation was lower in the S473A mutant than in the T450A/S473A mutant (B45% compared with T450A/S473A) ( Figure 5c , lane 6 versus lane 11). These observations suggest that the negative regulation of A-loop phosphorylation by TM phosphorylation is at least partially mediated by a decrease in the efficiency of phosphorylation by PDK1.
HM phosphorylation enhances A-loop phosphorylation independently of TM phosphorylation Phosphorylation of the HM overcomes the negative effect of TM phosphorylation on A-loop phosphorylation (Figure 4a , WT versus S473A), resulting in full activation of Akt. There are two possible mechanisms for this overriding activity: HM phosphorylation might inhibit the negative effect of TM phosphorylation or enhance A-loop phosphorylation regardless of TM phosphorylation. To assess the latter possibility, we investigated whether HM phosphorylation enhanced Figure 3 TM phosphorylation does not affect HM phosphorylation. WT or mutant hAkt (T308A, T308A/T450A) was expressed and phosphorylation state was analyzed at the times indicated after the addition of 1-MeAde, as described in Figure 1b . The phosphorylation of Akt (pT450 and pS473) after a 3-min incubation was quantified and normalized against total amounts of Akt. The graphs indicate phosphorylation levels relative to WT as mean values±s.d. from four different experiments.
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A-loop phosphorylation in the absence of TM phosphorylation. In the presence of HM phosphorylation, a three-fold increase in A-loop phosphorylation was observed in the T450A mutant compared with the T450A/S473A mutant ( Figure 6 , T450A versus T450A/ S473A), suggesting that HM phosphorylation can enhance A-loop phosphorylation independently of TM phosphorylation. Interestingly, A-loop phosphorylation was enhanced in the T450A mutant (Btwo-fold) compared with the WT (Figure 6 ), implying that the negative effect of TM phosphorylation could, at least partially, affect the level of A-loop phosphorylation even in the presence of HM phosphorylation. In addition, HM phosphorylation in the T450A mutant tended to increase (B1.2-fold) compared with the WT (Figure 6 ). An interpretation of this observation is discussed later.
TM phosphorylation decreases the biological activity of Akt in vivo The biological significance of the inhibition of A-loop phosphorylation by TM phosphorylation was assessed by measuring Akt activity. A PH domain-deleted and membrane-targeted form of Akt (myr-DPH Akt), achieved by fusion of a myristoylation signal, has constitutive activity via constitutive A-loop and HM phosphorylation in mammalian cells (Kohn et al., 1996) . Consistently, this form of Akt, but not the kinase-dead mutant (myr-DPH-K179A), induced GVBD when expressed in immature starfish oocytes (Table 1) (Okumura et al., 2002) . The kinetics of GVBD induction upon mRNA injection was determined in myr-DPH hAkt Alamutants. Immunoblot analysis showed that all of the mutants were translated with similar efficiency in immature oocytes except the myr-DPH-K179A mutant (Figure 7 ), indicating that the negative regulation by TM phosphorylation functions on myr-DPH hAkt. When 10 pg of mRNA was injected, the myr-DPH-S473A mutant did not induce GVBD within 8 h of injection, whereas the myr-DPH-T450A/ S473A mutant induced GVBD in all oocytes (Table 1 ). In addition, the expression level of the myr-DPH-S473A mutant at 8 h was higher than that of the myr-DPH-T450A/S473A mutant at GVBD (Figure 7a , right panels). These results clearly indicate that the myr-DPH-T450A/ S473A mutant has higher GVBD-inducing activity than the myr-DPH-S473A mutant, and that the difference in activity correlates with the difference in A-loop phosphorylation. When 3.5 pg of mRNA was injected, the myr-DPH-T450A mutant induced GVBD more rapidly than myr-DPH-WT despite lower expression than myr-DPH-WT (Table 1 and Figure 7b , right panels), indicating higher activity; however, no GVBD-inducing activity was detectable in the myr-DPH-T450A/S473A mutant, in accordance with the extent of A-loop phosphorylation. These results suggest that TM phosphorylation has a negative role in the biological activity of Akt in vivo through negative regulation of A-loop phosphorylation.
Discussion
This study demonstrates that phosphorylation of the TM and HM of Akt depends on TOR in starfish After an additional 1-h incubation, the oocytes were re-treated with 1-MeAde (2nd 1-MeAde) or injected with OA as described above, followed by immunoblot. As a control for OA injection, DMSO was injected. The phosphorylation levels at Thr308 (pT308) after 2nd 1-MeAde treatment and OA injection were quantified and normalized against total amounts of Akt. The graphs indicate phosphorylation level in S473A relative to that in T450A/S473A as mean values±s.d. from three different experiments. **P ¼ 4.35 Â 10 À4 , ***P ¼ 0.00478. Figure 6 HM phosphorylation enhances A-loop phosphorylation regardless of TM phosphorylation. WT or mutant hAkt (T450A, T450A/S473A) was expressed and phosphorylation state was analyzed at the times indicated after addition of 1-MeAde, as described in Figure 1b . The phosphorylation of Akt (pT308 and pS473) after a 3-min incubation was quantified and normalized against total amounts of Akt. The graphs indicate phosphorylation levels relative to WT as mean values±s.d. from four different experiments. *P ¼ 3.00 Â 10
À4
, **P ¼ 0.00238, ***P ¼ 0.00513.
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oocytes, as is the case in mammalian somatic cells. On the basis of this finding, our results reveal that TM phosphorylation renders Akt more susceptible to dephosphorylation of the A-loop, which is a novel aspect of Akt regulation (Figure 8b ). This negative effect indeed reduces the biological activity of Akt (Figure 8a ). In addition, to achieve maximal activation of Akt, HM phosphorylation is required to maintain the phosphate on the A-loop (Figure 8b ).
Regulation of A-loop phosphorylation via TM phosphorylation in vivo
To our knowledge, this study provides the first evidence that TM phosphorylation is involved in the control of A-loop phosphorylation. Two mechanisms may be having a role: TM phosphorylation may decrease the sensitivity of Akt to the A-loop kinase PDK1 and/or increase sensitivity to the A-loop phosphatase. Our study using OA (Figure 5c ) supports the former mechanism. An attractive hypothesis is the existence of cofactors working in conjunction with TM phosphorylation. Akt-binding proteins, such as Hsp90 (Sato et al., 2000; Basso et al., 2002) , TRB3 and PAK (Du et al., 2003; Du and Tsichlis, 2005; Higuchi et al., 2008) , have been reported to regulate negatively or positively the phosphorylation status of Akt. It would be interesting to evaluate the relationship between their binding ability and TM phosphorylation. In addition to TM phosphorylation, the amount of cofactors may determine whether or not HM phosphorylation is required for A-loop phosphorylation. HM phosphorylation can enhance A-loop phosphorylation independently of TM phosphorylation (Figure 6 ). By contrast, the effect of A-loop phosphorylation on HM phosphorylation seems more complex. Considering the results shown in Figures 3 and 6 , the level of HM phosphorylation in the T450A mutant (B1.2-fold compared with WT, Figure 6 ) was higher than in the T308A/ T450A mutant (equal to the WT, Figure 3 ). This suggests that A-loop phosphorylation modestly enhances HM phosphorylation in the absence of TM phosphorylation; however, in the presence of TM phosphorylation, A-loop phosphorylation did not affect HM phosphorylation (Figure 3 , WT versus T308A). A possible interpretation of these observations is that TM phosphorylation may sever the link from A-loop to HM phosphorylation. Abbreviations: GVBD, germinal vesicle breakdown; hAkt, human Akt; WT, wild type. Immature starfish oocytes were injected with the mRNAs (10 or 3.5 pg) encoding constitutively active hAkt (myr-DPH-WT) or its Ala mutants and GVBD was monitored. The time to GVBD is shown as mean ± s.d. The percentage of GVBD was calculated at 8 h after injection. The data are representative of two separate experiments (the same one is analyzed in Figure 7 ). 'N' indicates the number of oocytes monitored in the experiment. *P ¼ 9.7 Â 10 À5 , **P ¼ 7.4 Â 10
À5
. Figure 7 TM phosphorylation negatively affects the biological activity of hAkt in vivo. Immature starfish oocytes were injected with the mRNAs (a: 10 pg, b: 3.5 pg) encoding constitutively active hAkt (myr-DPH-WT) or its Ala-mutants. Oocytes were collected before GVBD was observed (at 2.5 h after injection, left panels) and after GVBD was observed (at GVBD, right panels). When GVBD was not observed, the oocytes were collected at 8 h (right panels). See Table 1 for time and rate of GVBD. The phosphorylation states of myr-DPH hAkt and Cdc2 (pY15) were analyzed by immunoblotting. Total amounts of myr-DPH hAkt Ala-mutant was quantified and indicated as ratio to myr-DPH-WT.
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TOR-dependent phosphorylation of Akt in starfish oocytes Akt activation has previously been reported in mouse and bovine oocytes (Tomek and Smiljakovic, 2005; Kalous et al., 2006) ; however our present observations represent the first indication that the TOR protein is required for the phosphorylation of both the TM and HM in oocytes. Although other components of the sfTOR complex remain to be identified, TORC2 rather than TORC1 is likely responsible for phosphorylation of both sites in starfish oocytes (Figure 2c , Supplementary  Figures S3c-e) .
Injection of OA induced phosphorylation on the Aloop, TM and HM (Figure 5a ). Assuming that the same kinase is responsible for TM and HM phosphorylation in both 1-MeAde-stimulated (Figure 2c ) and -unstimulated oocytes, TORC2 might have basal activity and might be responsible for OA-induced phosphorylation on the TM and HM. Thus, a simple explanation of OAinduced phosphorylation is the presence of OA-sensitive phosphatases that counteract both TM and HM phosphorylation. However only TM phosphorylation, and not HM phosphorylation, became detectable later in the absence of 1-MeAde stimulus (Figure 1c ) and was maintained after short exposure to 1-MeAde (Figure 5b ). These results imply that basal TORC2 activity might also cause TM phosphorylation in immature oocytes and that the putative TM phosphatase seems to reduce, but not suppress, the efficiency of the phosphorylation. By contrast, the putative HM phosphatase could contribute to maintaining the HM unphosphorylated by counteracting basal TORC2 activity in immature oocytes. These observations also imply that the TM of endogenous sfAkt is phosphorylated in immature oocytes. After anti-sfTOR injection, such phosphate on the TM of endogenous Akt would be gradually reduced by the putative TM phosphatase.
Generality and physiological significance of the novel role of TM phosphorylation The use of starfish oocytes as a model system revealed a novel role for TM phosphorylation and raises the question as to whether this type of regulation may be specific to this system. Previous reports using Ala mutants of hAkt in mammalian cells are consistent with our observation of the phosphorylation state of Ala-substitution mutants T308A (Goren et al., 2008) , S473A (Scheid et al., 2002; Jiang and Qiu, 2003; Goren et al., 2008) and T450A (Hauge et al., 2007) . Thus, although conflicting results were also reported in some cases (Toker and Newton, 2000; Hill et al., 2001) , our results obtained using Ala mutants do not seem to be specific to starfish oocytes. In addition, discrepancies in the A-loop phosphorylation status in experiments, in which mTORC2 was inhibited by different methods (see Introduction) may be explained by differences in levels of TM phosphorylation. Short-term inhibition by chemical inhibitors or RNA interference may have resulted in incomplete removal of the phosphate on the TM domain due to a low turnover rate of TM phosphorylation, whereas long-term inhibition in mouse embryonic fibroblasts from mTORC2 component-knockout mice may have caused complete removal of TM phosphorylation. If TM phosphorylation-dependent machinery capable of suppressing A-loop phosphorylation exists in these examples, differences in A-loop phosphorylation may reflect differences in TM phosphorylation. In fact, a rational pattern of TM phosphorylation has been observed in some cases (Feldman et al., 2009) . Although TM phosphorylation and its contribution to A-loop phosphorylation need to be re-evaluated in each case, these previous reports suggest that the novel regulatory mechanism revealed in this study could be applicable to mammalian cells. The illustration shows a model for the control of Akt phosphorylation. Both TM and HM phosphorylation depend on TOR (thin black arrow), possibly TORC2 because TORC1 is not required for the phosphorylation of all three conserved sites. TM phosphorylation renders Akt more susceptible to dephosphorylation of the A-loop (red arrow). Reduction in the sensitivity to PDK1 is likely the underlying mechanism, whereas increase in the sensitivity to A-loop phosphatase is not excluded. In the absence of HM phosphorylation, the phosphate on the A-loop cannot be maintained even in the presence of an agonist. To achieve maximum activation, HM phosphorylation enhances A-loop phosphorylation independently of TM phosphorylation (white arrow), thus ensuring A-loop phosphorylation (gray arrow). The negative role of TM phosphorylation seems to function even in the presence of HM phosphorylation, whereas the possibility of partial suppression of this negative effect by HM phosphorylation (dashed line) cannot be excluded. The boxes indicate the balance between PDK1 activity and A-loop phosphatase activity.
What is the physiological significance of this type of regulation? The TM seems to be already phosphorylated in unstimulated immature starfish oocytes (Figure 1c) , as well as in mammalian cells. As PDK1 is a constitutively active kinase (Alessi et al., 1997a; Hiraoka et al., 2004) , the A-loop of Akt is thought to be protected from phosphorylation by steric hindrance of the PH domain and by a counteracting phosphatase in unstimulated cells ( Figure 5 ) (Alessi et al., 1997a) . We propose TM phosphorylation as the third mechanism maintaining the A-loop unphosphorylated and thus keeping cells in an unstimulated state. Indeed, the negative effect of TM phosphorylation can work in the absence of 1-MeAde stimuli and, at least in part, without phosphatase and PH domain (Figures 5c and 7) . After stimulation, the negative effect of TM phosphorylation may affect the substrate specificity of Akt because it has been suggested that A-loop-phosphorylated Akt, in the absence of HM phosphorylation, is partially active and has a different substrate specificity than fully phosphorylated Akt (Jacinto et al., 2006) . The negative effect of TM phosphorylation would suppress such partial activation of Akt and subsequent signaling, even under agonist stimulation.
In conclusion, this study demonstrates that TM phosphorylation negatively regulates the A-loop phosphorylation and the biological activity of Akt by altering the balance between sensitivity to PDK1 and sensitivity to A-loop phosphatase(s) in vivo. Although the underlying mechanism and physiological significance require further investigation, our findings provide clues to solving the complex molecular mechanism that regulates the phosphorylation state of Akt in the cell.
Materials and methods
Oocyte preparation
Immature oocytes were isolated from the starfish Asterina pectinifera (Hiraoka et al., 2004) . To induce meiotic resumption, oocytes were treated with 0.5 mM 1-MeAde. For short treatment with 1-MeAde, which is not sufficient to induce meiotic resumption (Guerrier and Doree, 1975) , 1-MeAde was washed out 3 min after its addition by three washes of fresh seawater, each wash representing a 400-fold dilution. After incubation at 20 1C for 1 h, oocytes were re-treated with 1-MeAde or microinjected with OA.
DNA constructs
Human Akt1 (hAkt1) complementary DNA (accession No NM005103) was purchased from OriGene (Rockville, MD, USA). Full-length hAkt complementary DNA was inserted into the pSP64-S vector (a gift from Dr Terasaki) with the A. pectinifera cyclin B kozak sequence (5 0 -TACAAT-3 0 ). To generate a constitutively active form of hAkt (myr-DPH hAkt), the PH-domain (Val4-Ser129) was deleted and a myristoylation signal (MGSSKSKPKDPSQR) was fused to the N-terminus. Point mutations were generated by site-directed mutagenesis using PCR and were verified by sequencing.
Antibodies
An anti-phospho-starfish Akt (Ser477) rabbit polyclonal antibody was raised against a KLH-conjugated synthetic phospho-peptide corresponding to amino acids 472-482 (CQFEKFpSYSGDK) and was affinity purified with the peptide antigen. Preparation of an anti-starfish Akt Cterminus rabbit polyclonal antibody has been described previously (Okumura et al., 2002) . To generate an anti-sfTOR antibody, a His-tagged partial fragment of sfTOR (1062 amino acids, Met359-Ala1420) was expressed in E. coli, then purified using ProBond Resin (Invitrogen, Carlsbad, CA, USA). A rabbit polyclonal antibody was raised against the sfTOR fragment and affinity purified with the same fragment tagged with glutathione S-transferase. The control IgG for microinjection was purified from rabbit pre-immune serum with Protein A-Sepharose 4B (Sigma, St Louis, MO, USA). For microinjection, the solvent was replaced with injection buffer (phosphate-buffered saline, 0.1% NP-40). Anti-phosphohAkt1 (Thr308, Thr450 and Ser473) rabbit polyclonal antibodies and anti-hAkt1 C-terminus mouse monoclonal antibody were purchased from Cell Signaling (Danvers, MA, USA). Secondary antibodies for immunoblots were peroxidase-conjugated anti-rabbit IgG (GE Healthcare, Little Chalfont, UK) or anti-mouse IgG (Dakopatts, Glostrup, Denmark). An anti-PSTAIR antibody for Cdc2 was a gift from M Yamashita and Y Nagahama (National Institute for Basic Biology, Okazaki, Japan) and an anti-phospho-Tyr15 of Cdc2 antibody was purchased from Cell Signaling Technology.
Microinjection
Microinjection was performed as previously described (Kishimoto, 1986 ). The mRNAs encoding WT and mutant hAkt were transcribed from pSP64-S constructs using the mMES-SAGE mMACHINE kit (Ambion, Austiin, TX, USA), dissolved in water and injected into immature oocytes (5 pg per oocyte). After incubation for 3 h at 20 1C, oocytes were treated with 1-MeAde and sodium dodecyl sulphate-PAGE samples were prepared. Expression levels of hAkt protein were about five times those of endogenous Akt, and normal meiotic re-initiation was observed in hAkt-expressing oocytes. An affinity-purified anti-sfTOR antibody was injected into immature oocytes at a final concentration of 75 mg/ml. OA was dissolved in 25% DMSO at a concentration of 50 mM and microinjected into oocytes at a final concentration of 2.5 mM.
Immunoblotting Five oocytes were suspended in 4 ml of seawater, added directly to 4 ml of 2 Â sodium dodecyl sulphate-PAGE sample buffer and immediately frozen in liquid nitrogen. After thawing, oocytes were lysed by vortexing and then boiled for 5 min. Samples were separated on polyacrylamide gels (9% for Akt, 6% for sfTOR), followed by immunoblotting as described (Hara et al., 2009) . Quantification was performed using Multi Gauge Ver 3.0 (Fujifilm, Tokyo, Japan).
